ILIAS Biologics, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2015-11-02
- Employees
- 51
- Market Cap
- -
- Website
- http://www.iliasbio.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety and Tolerability of ILB-202
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- ILIAS Biologics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05843799
- Locations
- 🇦🇺
Adelaide, Adelaide, Australia
News
No news found